CUMBERLAND PHARMACEUTICALS INC (CPIX) research

CUMBERLAND PHARMACEUTICALS INC
ShareXLinkedInReddit
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Last price
$8.20
As of

CUMBERLAND PHARMACEUTICALS INC (CPIX): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-28.

As of . Source: SEC EDGAR filings for CPIX. Method and limitations.

SHARE THIS CARD

Share the CPIX intelligence card

A branded snapshot of CPIX: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion CPIX intelligence card preview
Post to X
LIVE TERMINAL

See CPIX live in the terminal

Track CPIX's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live CPIX terminal, free

Active signals for CPIX

FREE, NO ACCOUNT

Every signal on CPIX, as it fires

You are seeing 5 of 8 signals recorded on CPIX since 2026-08-16.

The five above landed across 2 days. The other 3 were recorded on 1 other days. 7 of the 8 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in CPIX (2026Q2)

Manager / securityMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP 230770109 · 2026Q2$3.1M0.00%,
CITADEL ADVISORS LLCCUSIP 230770109 · 2026Q2$476K0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 230770109 · 2026Q2$155K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, CPIX

CPIX against its peers

CPIX's operating margin of -6.3% ranks in the 53rd percentile of 15 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-03-31.

MetricCPIXPeer medianPercentilen
Revenue FY44.5M USD71.3M USD3816
Gross marginn/a43.4%n/a11
Operating margin-6.3%-13.3%5315
Net margin-6.4%-36.5%7916
Return on equity-11.4%-31.9%7312

Peers (17): CWBHF, BGM, AAWH, GRUSF, JUSHF, ADCT, ZYBT, TLPH, LEEEF, SCYX, DERM, PLNH, TSNDF, CRDL, AKBA, ELTP, CRLBF. Left out: CTOR (no annual filing), INCR (period gap), ASRT (no annual filing), OGI (period gap), LFCR (no annual filing), PHBI (period gap), GSTK (no annual filing), IXHL (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (CPIX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more CPIX signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to CPIXand get the insider, 13F, options, and confluence read in one view.

Open the live CPIX terminal, free